{
    "title": "Sanofi, GSK launch trial for COVID-19 protein-based vaccine",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8692855/Sanofi-GSK-launch-trial-COVID-19-protein-based-vaccine.html",
    "date": "2020-09-03",
    "keywords": [
        "vaccine",
        "covid19",
        "sanofi",
        "candidate",
        "trial",
        "stage",
        "gsk",
        "phase",
        "technology",
        "coronavirus",
        "globe",
        "treatment",
        "reporting",
        "drugmaker",
        "testing",
        "december",
        "half",
        "year",
        "study",
        "safety",
        "tolerability",
        "response",
        "recombinant",
        "influenza",
        "adjuvant",
        "substance",
        "booster",
        "order",
        "government",
        "illness",
        "activity",
        "httpstmsnrtrs3airuz7",
        "race",
        "wider",
        "experience",
        "advantage",
        "group",
        "company",
        "translate",
        "bio",
        "mrna",
        "interview",
        "week",
        "ceo",
        "paul",
        "hudson",
        "confidence",
        "vaccineplusadjuvant",
        "britain",
        "union",
        "allocation",
        "plan",
        "world",
        "health",
        "organization",
        "month",
        "arthritis",
        "drug",
        "kevzara",
        "sudip",
        "blamont",
        "editing",
        "hogue",
        "uttareshv",
        "hugh",
        "lawson"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}